BridgeBio Pharma Inc (BBIO)
27.86
-1.14
(-3.93%)
USD |
NASDAQ |
Jun 14, 16:00
27.89
+0.03
(+0.11%)
After-Hours: 20:00
BridgeBio Pharma Shares Outstanding: 187.13M for April 25, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| April 25, 2024 | 187.13M |
| April 22, 2024 | 187.13M |
| April 01, 2024 | 187.12M |
| March 31, 2024 | 187.12M |
| March 08, 2024 | 184.45M |
| February 15, 2024 | 175.83M |
| December 31, 2023 | 175.08M |
| October 26, 2023 | 173.97M |
| September 30, 2023 | 174.13M |
| July 31, 2023 | 162.47M |
| June 30, 2023 | 161.42M |
| May 02, 2023 | 160.50M |
| April 24, 2023 | 160.50M |
| April 03, 2023 | 160.50M |
| March 31, 2023 | 160.44M |
| March 10, 2023 | 160.20M |
| February 16, 2023 | 151.37M |
| December 31, 2022 | 150.63M |
| October 28, 2022 | 149.48M |
| September 30, 2022 | 149.37M |
| July 29, 2022 | 148.25M |
| June 30, 2022 | 148.24M |
| April 29, 2022 | 147.69M |
| April 25, 2022 | 147.69M |
| March 31, 2022 | 147.69M |
| Date | Value |
|---|---|
| February 18, 2022 | 147.61M |
| December 31, 2021 | 147.34M |
| November 15, 2021 | 147.19M |
| October 29, 2021 | 147.17M |
| September 30, 2021 | 147.09M |
| July 30, 2021 | 149.77M |
| June 30, 2021 | 149.61M |
| April 30, 2021 | 149.28M |
| March 31, 2021 | 149.11M |
| February 19, 2021 | 148.96M |
| February 11, 2021 | 148.79M |
| February 09, 2021 | 148.79M |
| January 26, 2021 | 148.82M |
| December 31, 2020 | 122.85M |
| December 08, 2020 | 122.72M |
| November 30, 2020 | 122.70M |
| October 30, 2020 | 122.57M |
| October 02, 2020 | 122.60M |
| September 30, 2020 | 122.54M |
| August 05, 2020 | 122.36M |
| July 24, 2020 | 122.27M |
| June 30, 2020 | 122.25M |
| May 08, 2020 | 121.37M |
| April 15, 2020 | 121.37M |
| March 31, 2020 | 121.36M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
116.76M
Minimum
Aug 09 2019
187.13M
Maximum
Apr 22 2024
145.93M
Average
148.24M
Median
Shares Outstanding Benchmarks
| Alnylam Pharmaceuticals Inc | 126.49M |
| Pfizer Inc | 5.667B |
| Arcellx Inc | 53.50M |
| Biomarin Pharmaceutical Inc | 189.88M |
| Viking Therapeutics Inc | 110.27M |